February 06,2008
Sen. Grassley’s letter regarding the FDA, a pharmaceutical drug maker and a safety officer at the FDA
Please view the printer-friendly version of Senator Grassley’s letter regarding the FDA, a pharmaceutical drug maker and a safety officer at the FDA.
Next Article Previous Article
Recent News
- Crapo Statement on Meeting With CMS Administrator Nominee
- Finance Committee Advances HHS Secretary Nominee
- Crapo Statement at Executive Session to Vote on HHS Nominee
- Crapo, Wyden Announce Senate Finance Subcommittee Assignments
- Finance Committee Members Introduce Bipartisan Legislation to Ensure Medicare Patients’ Access to Cancer Detection Technologies